Series B funding round for Gilgamesh Pharmaceuticals raising $39M in December 2022
Series B funding round for Gilgamesh Pharmaceuticals raising $39M in December 2022
| Investor | Firm Type | Partner |
|---|
Prime Movers LabLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Syndicate | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 6 funding rounds. Current round is highlighted.
Total Raised
$88.2M
Top Valuation
-
Gilgamesh Pharmaceuticals raised $39M in a Series B round.
The round was announced on 12/01/22.
The round was led by Amy Kruse.